Neudle.com: cytoprotective agents

Differential
(Click to cross reference)

activities of daily living

advances in neurology

adverse drug reaction

Alzheimer's disease, preclinical

Alzheimer's disease, risk factors in

Alzheimer's disease, treatment of

amyloid beta protein

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, etiology of

amyotrophic lateral sclerosis, prognosis

amyotrophic lateral sclerosis, treatment of

aneurysm

aneurysm, intracranial

aneurysm, intracranial, delayed cerebral ischemia with

aneurysm, intracranial, treatment of

angiotensin II receptor blocker

antibiotics

anticoagulant, treatment

anticoagulant, treatment in CVD

atherosclerosis, generalized

autonomic dysfunction

brain transplantation

bulbar palsy

bulbar palsy, progressive

burning paresthesia

caffeine

calcium antagonist

calcium antagonist, side effects of

cardiac arrest

cardiac arrest and resuscitation

caspases

CAT scan

CAT scan, abnormal

CAT scan, disappearing lesion on

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, xenon-enhanced

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, complications with

cerebrovascular accident, neonatal

cerebrovascular accident, pathophysiology

cerebrovascular accident, prevention of

cerebrovascular accident, prognosis in

cerebrovascular accident, severity

cerebrovascular accident, spontaneous improvement after

cerebrovascular accident, surgical treatment of

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, time of presentation

cerebrovascular accident, volume

cerebrovascular accident, work up for

cerebrovascular disease

cerebrovascular disease, risk factors in

cerebrovascular disease, surgical treatment of

controversies in neurology

cooling therapy

coronary artery disease

craniectomy, decompressive

crying, pathologic

DATATOP study

degenerative diseases of CNS

dementia

dementia, cerebrovascular disease causing

dementia, incidence

dementia, prevention of

dementia, treatment of

disability, neurological

distal muscle weakness

dopamine agonist

dopamine receptor, D2

drug induced neurologic disorders

dying

dysarthria

dyskinesia, buccal lingual facial

dysphagia

efficacy

embolism

emergencies, neurologic

emergency medical technicians

emotional lability

encephalopathy, post traumatic

endarterectomy, carotid

endarterectomy, carotid-complications of

endarterectomy, carotid-indications for

endarterectomy, carotid-long term results

endarterectomy, carotid-morbidity and mortality with

endovascular therapy

enzyme inhibition

epidemiology of neurology

fibrinolytic agents, combined IA and IV

fibrinolytic agents, contraindications

fibrinolytic agents, intra-arterial local infusion

fibroblast growth factor

head injury, evaluation of

head injury, management of

head injury, pathophysiology of

head injury, prevention

head injury, prognosis in

headache

headache, treatment of

hemodilution

hemorrhage, intracranial, newborn

hemorrhage, periventricular

heparin

heralding manifestation

herpes simplex encephalitis, diagnosis of

histamine-2 receptor blockers

HMGcoA reductase inhibitors

hypotension, systemic

hypothermia

hypoxic encephalopathy

iatrogenic neurologic disorders

intracranial pressure monitoring

intraventricular hemorrhage

intrinsic hand muscles, wasting of

ischemic penumbra

Kleine-Levin syndrome

lacunar infarction

laughing, pathologic

L-dopa

leg weakness, unilateral

Lewy body

Lewy body disease, diffuse

mental status, evaluation of

middle cerebral artery, occlusion of

migraine, prophylaxis

migraine, treatment of

mild cognitive impairment

minocycline

monoamine oxidase inhibitors

mortality

motor neuron disease

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, diffusion weighted

MRI, early changes in CVA

MRI, false negative

MRI, mismatch between perfusion/diffusion

MRI, perfusion

MRS

multiple sclerosis

multiple sclerosis, monosymptomatic

multiple sclerosis, pathogenesis

multiple sclerosis, relapsing

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

muscle wasting, diffuse

N-acetyl-L-aspartic acid

nerve growth factor

neuroendocrinology

neurologic disease

neurologic disease, diagnoses of

neurologic evaluation

neurologic examination

neuropathology, brain

neuropathy

neuroprotective agents

nonsteroidal anti-inflammatory drug

old age, neurology of

Parkinson disease, diagnosis

Parkinson disease, drug induced

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinsonism syndrome

pathology

pineal

piracetam

platelet inhibiting drugs

prevention of neurologic disorders

prognosis

psychological testing

rasagiline

rehabilitation for neurologic disorders

risk-benefit assessment

safety

seizure

seizure, treatment of

simvastatin

sinemet

single photon emission computed tomography

sleep

sleep pathology and physiology

smell

sodium-glucoe cotransporter-2 inhibitors

stroke, progression of

subarachnoid hemorrhage

subarachnoid hemorrhage, treatment of

subthalamic nucleus

subthalamic nucleus deep brain stimulation

synucleinopathy

tea

tetracycline

thrombolysis, mechanical

tissue plasminogen activator, intravenous

treatment of neurologic disorder

tremor, thalamic stimulation for suppression of

tripping

vasospasm, cerebral

vegetables

vestibular function, tests of

vitamin A

vitamin D

vitamin E

vitamin supplementation

whites

wine

Showing articles 1400 to 1450 of 3460 << Previous Next >>

Reasons for Exclusion From Thrombolytic Therapy Following Acute Ischemic Stroke
Neurol 64:719-720, Cocho,D., et al, 2005

Spinal Cord Transient Ischemic Attacks: A Possible Role for Abciximab
Neurol 64: 761-762, Hussain, M.S., et al, 2005

Acute Tetrodotoxin-Induced Neurotoxicity After Ingestion of Puffer Fish
Ann Neurol 57:339-348, 309, Kiernan, M.C., et al, 2005

Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005

Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
NEJM 352:987-996, 1036, Stupp,R., et al, 2005

MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma
NEJM 352:997-1003, 1036, Hegi,M.E., et al, 2005

Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone
NEJM 352:10 978-986, 1036, Rutkowski,S., et al, 2005

The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005

Sonothrombolysis in Acute Ischemic Stroke for Patients Ineligible for rt-PA
Neurol 64:1052-1054, Eggers,J., et al, 2005

Prospective Reliability of the Stroke Doc Wireless/Site Independent Telemedicine System
Neurol 64:1058-1060, Meyer,B.C., et al, 2005

Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Clin Inf Dis 41:634-653, Roden, M.M.,et al, 2005

Update on Susacs Syndrome
Curr Opin Neurol 18:311-314, Gross,M. &Eliashar,R., 2005

Posterior Cerebral Artery Stroke
e medicine, Hill,M.D., 2005

Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Stroke 36:66-73, Hacke,W.,et al, 2005

Chasing "Chasing the Dragon" with MRI: Leukoencephalopathy in Drug Abuse
Br J Radiol 78:997-1004, Bartlett,E. &Mikulis,D.J., 2005

Underappreciated Statin-Induced Myopathic Weakness Causes Disability
Neurorehabil Neural Repair 19:259-263, Dobkin,B.H., 2005

Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome After Intra-Arterial Reperfusion Therapy
AJNR 26:1798-1803, Schwamm,L.,et al, 2005

Multiple Cerebral Microbleeds:MRI Marker of a Diffuse Hemorrhage-Prone State
J Neuroimaging 14:54-57, Chalela,J.A.,et al, 2004

Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004

Parenteral Metoclopramide for Acute Migraine: Meta-Analysis of Randomised Controlled Trials
BMJ 329:1369-1372, Colman,I.,et al, 2004

Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004

Fatal Inflammatory AIDS-Associated PML with High CD4 Counts on HAART: A New Clinical Entity?
Neurol 63:2452-2453, Di Giambenedetto,S.,et al, 2004

Intra-Arterial Thrombolysis of Complete Deep Cerebral Venous Thrombosis
Neurol 63:2444-2445, Liebetrau,M.,et al, 2004

Should Thrombolysis be Given to a Stroke Patient Refusing Therapy Due to Profound Anosognosia?
Neurol 63:2440, Katz,J.M. &Segal,A.Z., 2004

Fibrinogen-Depleting Agents for Acute Ischemic Stroke
Stroke 36:173-174, Liu,M.,et al, 2004

Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004

Early MRI Findings in Patients Receiving Tissue Plasminogen Activator Predict Outcome: Insights into the Pathophysiology of Acute Stroke in the Thrombolysis Era
Ann Neurol 55:105-112, Chalela,J.A.,et al, 2004

Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke
Stroke 35:147-150, Brown,D.L.,et al, 2004

Steroids Have No Role in Stroke Therapy
Stroke 35:229-231, Poungvarin,N.,et al, 2004

Steroids May Have a Role in Stroke Therapy
Stroke 35:228-229,230, Norris,J.W., 2004

Magnetic Resonance Imaging Improves Detection of Intracerebral Hemorrhage Over Computed Tomography after Intra-Arterial Thrombolysis
Stroke 35:491-495, Greer,D.M.,et al, 2004

Clinical and MRI Outcome after Autologous Hematoipoietic Stem Cell Transplantation in MS
Neurol 62:282-284,168, Saiz,A.,et al, 2004

Reversible Abnormalities of DWI in High-Altitude Cerebral Edema
Neurol 62:335-336, Wong,S.H.,et al, 2004

Babesiosis and HIV
Lancet 363:704, Froberg,M.K.,et al, 2004

MR Imaging in Toxoplasmosis Encephalitis After Bone Marrow Transplantation: Paucity of Enhancement Despite Fulminant Disease
AJNR 25:270-273, Ionita,C.,et al, 2004

Liver Injury Associated with the B-Interferons for MS
Neurol 62:628-631, Tremlett,H.L.,et al, 2004

Cognitive Functions in Survivors of Primary Central Nervous System Lymphoma
Neurol 62:548-555,532, Correa,D.D.,et al, 2004

Cognitive Status and Quality of Life After Treatment for Primary CNS Lymphoma
Neurol 62:544-547,532, Harder,H.,et al, 2004

Effects of Cholesterol-lowering with Simvastatin on Stroke and Other Major Vascular Events in 20 536 People with Cerebrovascular Disease or Other High-Risk Conditions
Lancet 363:757-767, Heart Protection Study Collaborative Group, 2004

Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Arch Neurol 61:346-350, Katzan,I.L.,et al, 2004

Association of Outcome with Early Stroke Treatment:Pooled Analysis of ATLANTIS, ECASS, and NINDS rt-PA Stroke Trials
Lancet 363:768-774, The ATLANTIS,ECASS,and NINDS rt-PA Study Group, 2004

Contrast Enhancement and Contrast Extravasation on Computed Tomography After Intra-Arterial Thrombolysis in Patients with Acute Ischemic Stroke
Stroke 35:876-881, Yoon,W.,et al, 2004

Combined Intravenous and Intra-Arterial Recanalization for Acute Ischemic Stroke:The Interventional Management of Stroke Study
Stroke 35:904-911, The IMS Study Investigators, 2004

Therapy for Nerve Agent Poisoning
Arch Neurol 61:649-652, Newmark,J., 2004

Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004

Treatment of Refractory Neurosarcoidosis with Cladribine
NEJM 350:1798-1799, Tikoo,R.K.,et al, 2004

Clinicopath Conf., Progessive Multifocal Leukoencephalopathy
NEJM 350:1884-1893, Case 14-2004, 2004

Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins
Stroke 35:1117-1123, Marti-Fabregas,J.,et al, 2004

Oral Simvastin Treatment in Relapsing-Remitting Multiple Sclerosis
Lancet 363:1607-1608,1570, Vollmer,T.,et al, 2004

Showing articles 1400 to 1450 of 3460 << Previous Next >>